BUZZ-Moderna gains after receiving COVID-19 vaccine supply tender

Shares of vaccine maker Moderna MRNA.O gain 1.9% to $43.18 premarket

Co has been awarded tender to supply its mRNA COVID-19 vaccine in the European Union, Norway and North Macedonia, allowing 17 countries to access the vaccine for up to four years

Tender comes after MRNA cut its 2025 sales forecast by $1 bln earlier this month, partially due to weak demand for its COVID-19 vaccines

The trim brought co's FY25 revenue forecast below analysts' estimates and sent shares down nearly 17% on Jan. 13

Seven of 26 brokerages covering stock rate it "buy", 15 rate "hold" and four rate "sell" or lower; median PT is $57 - LSEG data

MRNA stock more than halved in 2024